Chemoinformaics analysis of RUBROFUSARIN-GENTIOBIOSIDE
| Molecular Weight | 596.538 | nRot | 7 |
| Heavy Atom Molecular Weight | 564.282 | nRig | 29 |
| Exact Molecular Weight | 596.174 | nRing | 5 |
| Solubility: LogS | -2.954 | nHRing | 3 |
| Solubility: LogP | -0.679 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 16 |
| nHA | 15 | APOL | 78.4574 |
| nHD | 8 | BPOL | 43.3866 |
| QED | 0.137 |
| Synth | 4.779 |
| Natural Product Likeliness | 1.832 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.991 |
| HIA | 0.977 |
| CACO-2 | -6.298 |
| MDCK | 0.000111336 |
| BBB | 0.436 |
| PPB | 0.615727 |
| VDSS | 0.576 |
| FU | 0.277577 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.454 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.259 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.183 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.005 |
| CL | 1.263 |
| T12 | 0.272 |
| hERG | 0.033 |
| Ames | 0.576 |
| ROA | 0.025 |
| SkinSen | 0.024 |
| Carcinogencity | 0.186 |
| EI | 0.007 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.748 |
| Antiviral | Yes |
| Prediction | 0.74112 |